MICRO-LEADS INC

Micro-Leads is a medical device technology company developing injectable and laparoscopic, surgery-free devices for precision neurostimulation. Its closed-loop platform reads the body's physiological response to stimulation and writes an adaptive stimulation therapy, enabling high-resolution spinal cord stimulation, peripheral nerve stimulation, and brain-computer interfaces. The company's flagship products include the Expand-X needle-injected nerve stimulator, the HD64 high-density electrode array, and the Propel closed-loop neurostimulator platform. Micro-Leads has completed an FDA IDE clinical study and holds multiple patents covering multi-electrode array architectures designed for scalable, robust implantable neurotechnology.